The association of coeliac disease and partial lipodystrophy is described. The patient also had deficiencies of serum IgA and C3 complement (the latter associated with partial lipodystrophy). In addition, there was subclinical dermatitis herpetiformis confirmed by skin biopsy. The 
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Abstract The association of coeliac disease and partial lipodystrophy is described. The patient also had deficiencies of serum IgA and C3 complement (the latter associated with partial lipodystrophy). In addition, there was subclinical dermatitis herpetiformis confirmed by skin biopsy. The Case report Our patient, an 18 year old white woman, had been diagnosed as having CD at the age of 7. The diagnosis had been made after examination of a small intestinal biopsy specimen. She was started on a gluten free diet and remained on this until she was 10, at which time she stopped the diet. Nine months later she presented to the paediatrics department of this hospital with reactivated steatorrhoea. A repeat jejunal biopsy specimen showed subtotal villous atrophy and she restarted the gluten free diet. The villous atrophy resolved and her steatorrhoea stopped. At that time she also had symptomatic bronchial asthma that required treatment with a bronchodilator.
Despite the apparently satisfactory treatment of her CD, persistent severe wasting of the face, upper limbs, and trunk -contrasting with normal appearances of the pelvis and lower limbs -was noted at outpatient follow up over a one year interval after reversal of the subtotal villous atrophy. She was questioned about her diet but this seemed adequate. Her serum thyroxine value was normal. PL was suspected clinically. lower limb appearance and the facial wasting in particular should arouse suspicion (Fig 2) , particularly when a small intestinal biopsy specimen shows controlled CD.
PL is associated with a serum complex, the socalled C3 nephritic factor,9 which seems to stabilise the C3 convertase enzyme in plasma resulting in accelerated C3 complement factor degradation. Thus (Figs 1 and 2 ).
